Functional nicotinic acetylcholine receptors containing α6 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons

J Neurosci. 2011 Feb 16;31(7):2537-48. doi: 10.1523/JNEUROSCI.3003-10.2011.

Abstract

Diverse nicotinic acetylcholine receptor (nAChR) subtypes containing different subunit combinations can be placed on nerve terminals or soma/dendrites in the ventral tegmental area (VTA). nAChR α6 subunit message is abundant in the VTA, but α6*-nAChR cellular localization, function, pharmacology, and roles in cholinergic modulation of dopaminergic (DA) neurons within the VTA are not well understood. Here, we report evidence for α6β2*-nAChR expression on GABA neuronal boutons terminating on VTA DA neurons. α-Conotoxin (α-Ctx) MII labeling coupled with immunocytochemical staining localizes putative α6*-nAChRs to presynaptic GABAergic boutons on acutely dissociated, rat VTA DA neurons. Functionally, acetylcholine (ACh) induces increases in the frequency of bicuculline-, picrotoxin-, and 4-aminopyridine-sensitive miniature IPSCs (mIPSCs) mediated by GABA(A) receptors. These increases are abolished by α6*-nAChR-selective α-Ctx MII or α-Ctx PIA (1 nm) but not by α7 (10 nm methyllycaconitine) or α4* (1 μm dihydro-β-erythroidine)-nAChR-selective antagonists. ACh also fails to increase mIPSC frequency in VTA DA neurons prepared from nAChR β2 knock-out mice. Moreover, ACh induces an α-Ctx PIA-sensitive elevation in intraterminal Ca(2+) in synaptosomes prepared from the rat VTA. Subchronic exposure to 500 nm nicotine reduces ACh-induced GABA release onto the VTA DA neurons, as does 10 d of systemic nicotine exposure. Collectively, these results indicate that α6β2*-nAChRs are located on presynaptic GABAergic boutons within the VTA and modulate GABA release onto DA neurons. These presynaptic α6β2*-nAChRs likely play important roles in nicotinic modulation of DA neuronal activity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Acetylcholine / pharmacology
  • Aconitine / analogs & derivatives
  • Aconitine / pharmacology
  • Animals
  • Animals, Newborn
  • Bungarotoxins / pharmacology
  • Calcium / metabolism
  • Conotoxins / metabolism
  • Dihydro-beta-Erythroidine / pharmacology
  • Dopamine / metabolism*
  • Dopamine / pharmacology
  • Drug Interactions
  • Excitatory Amino Acid Agents / pharmacology
  • Female
  • GABA Agents / pharmacology
  • Glutamate Decarboxylase / metabolism
  • In Vitro Techniques
  • Inhibitory Postsynaptic Potentials / drug effects
  • Male
  • Mice
  • Mice, Knockout
  • Neurons / cytology*
  • Neurons / drug effects
  • Nicotine / pharmacology
  • Nicotinic Antagonists / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / physiology*
  • Protein Binding / drug effects
  • Rats
  • Rats, Wistar
  • Receptors, Nicotinic / deficiency
  • Receptors, Nicotinic / metabolism*
  • Synaptosomes / drug effects
  • Synaptosomes / metabolism
  • Ventral Tegmental Area / cytology*
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Bungarotoxins
  • Conotoxins
  • Excitatory Amino Acid Agents
  • GABA Agents
  • Nicotinic Antagonists
  • Potassium Channel Blockers
  • Receptors, Nicotinic
  • nicotinic receptor alpha6
  • nicotinic receptor beta2
  • methyllycaconitine
  • Dihydro-beta-Erythroidine
  • gamma-Aminobutyric Acid
  • Nicotine
  • 4-Aminopyridine
  • Glutamate Decarboxylase
  • glutamate decarboxylase 2
  • Acetylcholine
  • Calcium
  • Dopamine
  • Aconitine